NCT06553508

Brief Summary

During total hip arthroplasty surgery, the trochanteric bursa is routinely excised. This anatomical structure, which functions as a soft tissue barrier, is generally recommended for removal as it facilitates the surgical approach. However, recent studies have suggested that the trochanteric bursa is an important soft tissue barrier and may protect against infections. The aim of this study is to evaluate the differences in infection rates, wound complications, deep gluteal syndrome presence, pain, and clinical scores within the first 90 days between patients in whom the trochanteric bursa was repaired and those in whom it was not, and to provide recommendations regarding bursal repair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 14, 2024

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

12 months

First QC Date

August 12, 2024

Last Update Submit

August 14, 2024

Conditions

Keywords

bursagreater trochanterhip arthroplastydeep gluteal syndromepiriformis syndrome

Outcome Measures

Primary Outcomes (3)

  • Rate of superficial wound problems

    Wound leakage, superficial infection, wound dehiscence - Recorded as Yes / No

    First postoperative 90 days

  • Rate of posterior gluteal pain

    The condition is also refered to as Deep Gluteal Syndrome - Recorded as Yes / No

    First postoperative 90 days

  • Rate of painful trochanteric bursitis

    Recorded as pain on the trochanteric region on palpation - Recorded as Yes / No

    First postoperative 90 days

Secondary Outcomes (3)

  • Range of motion (ROM)

    First postoperative 90 days

  • Visual Analog Scale (VAS)

    First postoperative 90 days

  • Harris Hip Score (HHS)

    First postoperative 90 days

Study Arms (2)

Unrepaired bursa group

ACTIVE COMPARATOR

As a routine procedure in our centre, the trochanteric bursa is left unrepaired after a hip arthroplasty. The conventional joint closure is performed after reduction and the layers are closed in a routine fashion.

Procedure: Trochanteric bursa unrepaired

Repaired Bursa group

EXPERIMENTAL

For the experimental arm, the trochanteric bursa is repaired after a hip arthroplasty. The conventional joint closure is performed after reduction and then the bursa is retrieved and repaired. Layers are then closed in a routine fashion.

Procedure: Trochanteric bursa repaired

Interventions

As a routine procedure in our centre, the trochanteric bursa is left unrepaired after a hip arthroplasty.

Repaired Bursa group

For the experimental arm, the trochanteric bursa is repaired after a hip arthroplasty. The conventional joint closure is performed after reduction and then the bursa is retrieved and repaired.

Unrepaired bursa group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 18 to 90 years of age
  • With a diagnosis of primary hip osteoarthritis
  • Willing to be included in the study

You may not qualify if:

  • Patients who had a known history of trochanteric bursitis, deep gluteal syndrome, sciatica, vertebral fracture, hip fracture, hip arthroscopy, and core decompression surgery
  • Patients who had a history of bursal injection within 6 months
  • Patients undergoing hip arthroplasty with a shortening osteotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, 06800, Turkey (Türkiye)

Location

Related Publications (3)

  • Schwartsmann CR, Loss F, de Freitas Spinelli L, Furian R, Silva MF, Zanatta JM, Boschin LC, Goncalves RZ, Yepez AK. Association between trochanteric bursitis, osteoarthrosis and total hip arthroplasty. Rev Bras Ortop. 2014 Apr 25;49(3):267-70. doi: 10.1016/j.rboe.2014.04.009. eCollection 2014 May-Jun.

    PMID: 26229811BACKGROUND
  • Shemesh SS, Moucha CS, Keswani A, Maher NA, Chen D, Bronson MJ. Trochanteric Bursitis Following Primary Total Hip Arthroplasty: Incidence, Predictors, and Treatment. J Arthroplasty. 2018 Apr;33(4):1205-1209. doi: 10.1016/j.arth.2017.11.016. Epub 2017 Nov 13.

    PMID: 29195847BACKGROUND
  • Moerenhout K, Benoit B, Gaspard HS, Rouleau DM, Laflamme GY. Greater trochanteric pain after primary total hip replacement, comparing the anterior and posterior approach: A secondary analysis of a randomized trial. Orthop Traumatol Surg Res. 2021 Dec;107(8):102709. doi: 10.1016/j.otsr.2020.08.011. Epub 2020 Oct 31.

    PMID: 33132093BACKGROUND

MeSH Terms

Conditions

Latent TuberculosisHip socket neuropathyPiriformis Muscle Syndrome

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsLatent InfectionSciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesNeuralgiaPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic Pain

Study Officials

  • Enejd Veizi, MD

    Ankara City Hospital Bilkent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 14, 2024

Study Start

January 1, 2022

Primary Completion

December 31, 2022

Study Completion

January 1, 2023

Last Updated

August 16, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations